J7180 – Injection, factor xiii (antihemophilic factor, human), 1 i.u.
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7180
- Long description
- Injection, factor xiii (antihemophilic factor, human), 1 i.u.
- Short description
- Factor xiii anti-hem factor
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2012
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J7180?
J7180 is a HCPCS Level II code for injection, factor xiii (antihemophilic factor, human), 1 i.u..
Does Medicare cover J7180?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7172 – Injection, marstacimab-hncq, 0.5 mg
- J7173 – Injection, concizumab-mtci, 0.5 mg
- J7174 – Injection, fitusiran, 0.04 mg
- J7175 – Injection, factor x, (human), 1 i.u.
- J7176 – Injection, human fibrinogen - chmt (fesilty), 1 mg
- J7177 – Injection, human fibrinogen concentrate (fibryga), 1 mg
- J7178 – Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
- J7179 – Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
- J7181 – Injection, factor xiii a-subunit, (recombinant), per iu
- J7182 – Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
- J7183 – Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
- J7185 – Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
- J7186 – Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
- J7187 – Injection, von willebrand factor complex (humate-p), per iu vwf:rco
- J7188 – Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
- J7189 – Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.